BETTERLIFE PHARMA INC. MATERIAL CHANGE REPORT
Name and Address of Company
BetterLife Pharma Inc. (the "Company")
1275 West 6th Avenue
Suite 300
Vancouver, British Columbia
V6H 1A6
Date of Material Change
January 2023 and December 2022
News Releases
N/A.
Summary of Material Change
On December 12, 2022, the Company granted 20,000 stock options with exercise price of $0.16 and expiry date of December 11, 2024 to a consultant. On January 13, 2023, the Company granted 1,800,000 stock options with exercise price of $0.16 and expiry date of January 12, 2023 to officers, directors and consultants.
On January 16, 2023, the Company filed a Notice of Meeting and Record Dates for its upcoming Annual General Meeting to be held on March 30, 2023 with a record date of February 10, 2023.
Full Description of Material Change
Refer to Item 4.
Reliance on subsection 7.1(2) or (3) of National Instrument 51-102
This Report is not being filed on a confidential basis in reliance on subsection 7.1(2) of National Instrument 51-102.
Omitted Information
No information has been omitted on the basis that it is confidential information.
Executive Officer
Further information can be obtained from Ahmad Doroudian, Chief Executive Officer of the Company, at (604) 221-0595.
Date of Report
January 17, 2023
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BetterLife Pharma Inc. published this content on 18 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 January 2023 14:09:03 UTC.
